Sjogren’s Syndrome Interview

Medical Condition: Sjogren’s Syndrome

Facility/Clinic: Accellacare

Age: 18 or older

Gender: Male/Female

Description: The purpose of this study is to evaluate the safety, activity and side effects of a new research drug compared to a placebo for people diagnosed with Sjogren’s Syndrome. This research study may be an option if you:

  • Have been diagnosed with Sjogren’s Syndrome
  • Have not been diagnosed with deep vein thrombosis or arterial thromboembolism within the last 2 years
  • Require treatment with anticoagulant drugs

Other criteria apply. Please make sure to discuss this study with a member of our research staff to ensure this research study is a good fit for you. Qualified participants will receive all study-related care and study medication at no cost.

Enrollment: Open

Patient Commitment Duration: Approximately 56 weeks

Number of visits in study: Approximately 15 clinic visits

Patient Compensation: Financial compensation will be provided for time and travel expenses.

The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.